INFECCIÓN RESPIRATORIA Y RESISTENCIA ANTIMICROBIANA
GlaxoSmithKline (Spain)
Madrid, EspañaPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (Spain) (3)
2005
-
Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972
-
In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point
International Journal of Antimicrobial Agents, Vol. 25, Núm. 2, pp. 163-167
2003
-
Genetic Relatedness of Recently Collected Spanish Respiratory Tract Streptococcus pneumoniae Isolates with Reduced Susceptibility to Amoxicillin
Antimicrobial Agents and Chemotherapy, Vol. 47, Núm. 11, pp. 3637-3639